NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 42 filers reported holding NEXTCURE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,488 | -29.1% | 43,014 | -1.1% | 0.00% | – |
| Q2 2023 | $78,253 | +22.9% | 43,474 | +1.1% | 0.00% | – |
| Q1 2023 | $63,661 | +5.4% | 43,014 | +0.4% | 0.00% | – |
| Q4 2022 | $60,410 | -49.2% | 42,844 | -1.3% | 0.00% | – |
| Q3 2022 | $119,000 | -40.2% | 43,392 | +2.4% | 0.00% | – |
| Q2 2022 | $199,000 | -4.3% | 42,371 | -1.0% | 0.00% | – |
| Q1 2022 | $208,000 | -20.9% | 42,816 | -2.4% | 0.00% | – |
| Q4 2021 | $263,000 | -7.7% | 43,854 | +3.8% | 0.00% | – |
| Q3 2021 | $285,000 | -9.8% | 42,233 | +7.7% | 0.00% | – |
| Q2 2021 | $316,000 | -83.0% | 39,227 | -78.9% | 0.00% | – |
| Q1 2021 | $1,863,000 | -16.8% | 186,023 | -9.5% | 0.00% | – |
| Q4 2020 | $2,239,000 | +20.8% | 205,438 | -2.4% | 0.00% | – |
| Q3 2020 | $1,853,000 | -62.1% | 210,476 | -7.7% | 0.00% | -100.0% |
| Q2 2020 | $4,889,000 | -22.9% | 228,023 | +33.3% | 0.00% | -50.0% |
| Q1 2020 | $6,342,000 | -32.2% | 171,053 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $9,358,000 | +512.4% | 166,126 | +235.4% | 0.00% | – |
| Q3 2019 | $1,528,000 | +353.4% | 49,525 | +120.3% | 0.00% | – |
| Q2 2019 | $337,000 | – | 22,479 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |